Attenuation of nociceptin/orphanin FQ-induced signaling by N-methyl-D- aspartate in neuronal cells

NeuroReport

Volumn 9, Issue 4, 1998, Pages 631-636

  Zhao, Jian ^a   Zhang, Yi ^a   Xin, Shun Mei ^a   Ma, Lan ^b   Pei, Gang ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Cyclic AMP assay; G protein activation; NMDA; Nociceptin orphanin FQ (N OFQ); ORL; Signaling modulation

Indexed keywords

ADENYLATE CYCLASE; CYCLIC AMP; ETORPHINE; GUANINE NUCLEOTIDE BINDING PROTEIN; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NOCICEPTIN; OPIATE RECEPTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DESENSITIZATION; DOSE RESPONSE; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYBRID CELL; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT;

EID: 0032498857     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199803090-00013     Document Type: Article

References (29)

1. Meunier JC, Mollereau C, Toll L et al. Nature 377, 532-535 (1995).
2. Reinscheid RK, Nothacker HP, Bourson A et al. Science 270, 792-794 (1995).
3. Sim LJ, Xiao R and Childers SR. NeuroReport 7, 729-733 (1996).
4. Vaughan CW and Christie MJ. J Pharmacol 117, 1609-1611 (1996).
5. Ma L, Cheng ZJ, Fan GH et al. FEBS Lett 403, 91-94 (1997).
6. Cheng ZJ, Fan GH, Zhao J et al. NeuroReport 8, 1913-1918 (1997).
7. Herman BH, Vocci F and Bridge P. Neuropsychopharmacology 13, 269-293 (1995).
8. Trujillo KA and Akil H. Science 251, 85-87 (1991).
9. Bhargava HN and Thorat SN. Brain Res 649, 111-116 (1994).
10. Tiseo PJ, Cheng J, Pasternak GW and Inturrisi CE. J Pharmacol Exp Ther 268, 195-201 (1994).
11. Trujillo KA, and Akil H. Brain Res 633, 178-188 (1994).
12. Wong CS, Cherng CH, Luk HN and Ho ST. Eur J Pharmacol 297, 27-33 (1996)
13. Mercadante S, Lodi F, Sapio M et al. J. Pain Symptom Manag 10, 564-568 (1995).
14. Cai YC, Ma L, Fan GH et al. Mol Pharmacol 51, 583-587 (1997).
15. Wang XM, Zhang KM and Mokha SS. J Neurophysiol 73, 3568-3572 (1996).
16. Ohkuma S, Katsura M, Chen DZ et al. Mol Brain Res 22, 166-172 (1994).
17. Cai YC, Zhang Y, Wu YL and Pei G. Biochem Biophys Res Commun 219, 342-347 (1996).
18. Hochhaus G, Yu VC and Sadee W. Brain Res 382, 327-331 (1986).
19. Traynor JR and Nahouaki SR. Mol Pharmacol 47, 848-854 (1995).
20. Sim LJ, Selley DE, Xiao R and Childers SR. Eur J Pharmacol 307, 97-105 (1996).
21. Hilf G, Gierscnik P and Jakobs KH. Eur J Biochem 186, 725-731 (1989).
22. Lazareno S, Farries T and Birdsall NJM. Life Sci 52, 449-456 (1993).
23. Tian W-N, Duzic E, Lanier SM and Deth RC. Mol Pharmacol 45, 524-531 (1994).
24. Bhargava HN, Matwyshyn GA and Gudehithlu KP. Pharmacology 51, 323-330 (1995).
25. Freedman NJ and Lefkowitz RJ. Recent Prog Hormone Res 51, 319-351 (1996).
26. Matthes HWD, Maldonadl R, Simonin F et al. Science 383, 819-823 (1996).
27. Toll L. J Pharmacol Exp Ther 273, 721-727 (1995).
28. Blake AD, Bot G, Li S et al. J Neurochem 68 1846-1852 (1997).
29. Namir N, Polastron J, Allouche S et al. J Neurochem 68, 1764-1772 (1996).